Monday, August 3, 2026

Unmanned Aerial Vehicles: How the Latest Tensions with North Korea Could Impact Regional Stability

The Blue House will investigate North Korea's drone incursion claims, emphasizing a lack of intent to provoke tensions.

Trump’s Tax Threat: What Happens If the Supreme Court Rules Against U.S. Tariffs?

Trump warns of potential trillions in refunds if tariffs ruled illegal, emphasizing chaos and complexity of the situation ahead.

18 New Korean Dishes to Debut at Korea House in Paris!

South Korean Ministry of Agriculture, Food and Rural Affairs and the Korean Food Promotion Institute announced that they will host ...

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

AI vs. Traditional Methods: Discover the Game-Changing Clinical Environment Simulator for Medical Evaluations

A new Clinical Environment Simulator (CES) evaluates medical AI in realistic settings, enhancing safety without risking patient lives.

Pet7 Launches Innovative Probiotic: A Comprehensive Guide for Dog Owners

Cha Bio F&C launches Pet7 Gut Care Probiotics to enhance canine digestive health with a blend of probiotics, prebiotics, and enzymes.

Revolutionizing Regenerative Medicine: How Noul’s AI Blood Analysis is Transforming Stem Cell Treatments

Noul partners with Infinite Medical to enhance its AI blood analysis tool, miLab™ BCM, for stem cell regenerative therapies.

Samjin Pharmaceutical and Ewha Womans University Seoul Hospital Sign MOU for Innovative Migraine Treatment

Samjin Pharmaceutical partners with Ewha Womans University Medical Center to develop treatments for CNS disorders, focusing on migraines.

Lunit’s 200 Billion KRW Funding: How Atinum Investment Boosts AI in Healthcare

Lunit secures 30 billion KRW investment from Atinum to enhance global R&D and operations, reinforcing its position in medical AI.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

How is Omlyclo Revolutionizing Allergy Treatment in Europe: Key Successes and Insights

Celltrion's Omlyclo treatment is rapidly gaining market share in Europe, winning tenders and expanding prescriptions across multiple countries.

Wontec’s Bold Move: 6 Billion KRW Buyback to Boost Shareholder Value in 2026

Wontech plans to repurchase shares worth 6 billion KRW to boost shareholder value and confidence, aiming for strong growth by 2025.

24-Hour Emergency Hotline: How GC’s New Service Supports Koreans in Vietnam

GC has partnered to launch a 24-hour emergency hotline for Koreans in Hanoi, enhancing access to medical services and support.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.